Year |
Citation |
Score |
2023 |
Lin W, Singh V, Springer R, Choonoo G, Gupta N, Patel A, Frleta D, Zhong J, Owczarek T, Decker C, Macdonald L, Murphy A, Thurston G, Mohrs M, Ioffe E, et al. Human CD4 cytotoxic T lymphocytes mediate potent tumor control in humanized immune system mice. Communications Biology. 6: 447. PMID 37185301 DOI: 10.1038/s42003-023-04812-3 |
0.362 |
|
2022 |
Wei J, Montalvo-Ortiz W, Yu L, Krasco A, Olson K, Rizvi S, Fiaschi N, Coetzee S, Wang F, Ullman E, Ahmed HS, Herlihy E, Lee K, Havel L, Potocky T, ... ... Frleta D, et al. CD22-targeted CD28 bispecific antibody enhances antitumor efficacy of odronextamab in refractory diffuse large B cell lymphoma models. Science Translational Medicine. 14: eabn1082. PMID 36350988 DOI: 10.1126/scitranslmed.abn1082 |
0.374 |
|
2009 |
Frleta D, Yu CI, Klechevsky E, Flamar AL, Zurawski G, Banchereau J, Palucka AK. Influenza virus and poly(I:C) inhibit MHC class I-restricted presentation of cell-associated antigens derived from infected dead cells captured by human dendritic cells. Journal of Immunology (Baltimore, Md. : 1950). 182: 2766-76. PMID 19234171 DOI: 10.4049/Jimmunol.0801720 |
0.368 |
|
2009 |
Frleta D, O'Brien M, Haynes B, Kessler B, Bhardwaj N. P10-05. Suppression of human dendritic cell function during acute HIV infection Retrovirology. 6. DOI: 10.1186/1742-4690-6-S3-P136 |
0.327 |
|
2003 |
Frleta D, Noelle RJ, Wade WF. CD40-mediated up-regulation of Toll-like receptor 4-MD2 complex on the surface of murine dendritic cells. Journal of Leukocyte Biology. 74: 1064-73. PMID 12960264 DOI: 10.1189/Jlb.0203062 |
0.372 |
|
2003 |
Frleta D, Lin JT, Quezada SA, Wade TK, Barth RJ, Noelle RJ, Wade WF. Distinctive maturation of in vitro versus in vivo anti-CD40 mAb-matured dendritic cells in mice. Journal of Immunotherapy (Hagerstown, Md. : 1997). 26: 72-84. PMID 12514431 DOI: 10.1097/00002371-200301000-00008 |
0.405 |
|
2001 |
Frleta D, Demian D, Wade WF. Class II-targeted antigen is superior to CD40-targeted antigen at stimulating humoral responses in vivo International Immunopharmacology. 1: 265-275. PMID 11360928 DOI: 10.1016/S1567-5769(00)00032-1 |
0.377 |
|
Show low-probability matches. |